Loading insider details...
Beta
Latest Form 4 (Jun 25, 2026): Grant/Award of 28,000 FHTX shares, $114.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 25, 2026 | Foghorn Therapeutics Inc. (FHTX) | Grant/Award | 28,000 | $114.2K |
| Feb 17, 2026 | Serina Therapeutics, Inc. (SER) | Grant/Award | 92,000 | n/a |
| Jun 17, 2025 | Foghorn Therapeutics Inc. (FHTX) | Grant/Award | 25,000 | $119.8K |
| Jun 28, 2024 | Foghorn Therapeutics Inc. (FHTX) | Grant/Award | 16,000 | $88.3K |
| Apr 17, 2024 | Serina Therapeutics, Inc. (SER) | Grant/Award | 295,300 | n/a |
| Nov 8, 2023 | Evelo Biosciences, Inc. (EVLO) | Exercise/Conversion | 1,172 | n/a |
| Sep 29, 2023 | Evelo Biosciences, Inc. (EVLO) | Exercise/Conversion | 15,000 | n/a |
| Aug 9, 2023 | Evelo Biosciences, Inc. (EVLO) | Exercise/Conversion | 1,171 | n/a |
| Jun 23, 2023 | Foghorn Therapeutics Inc. (FHTX) | Grant/Award | 16,000 | n/a |
| Jun 12, 2023 | Evelo Biosciences, Inc. (EVLO) | Grant/Award | 1,000,000 | n/a |